HedgePath Pharmaceuticals (OTCMKTS:MAYNF) shares were up 6.9% during trading on Wednesday . The company traded as high as $0.35 and last traded at $0.35, approximately 1,000 shares changed hands during trading. A decline of 97% from the average daily volume of 32,645 shares. The stock had previously closed at $0.33.
Separately, Citigroup downgraded shares of HedgePath Pharmaceuticals from a “buy” rating to a “neutral” rating in a research report on Friday, May 17th.
The stock has a 50-day moving average price of $0.33.
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products worldwide. It operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The company also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers.
Read More: Depreciation
Receive News & Ratings for HedgePath Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HedgePath Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.